Approval · Notice of Compliance 35866 · 2025
NIMOTOP: Notice of Compliance 35866
Issued August 18, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35866
- Date
- August 18, 2025
- Company
- Laboratoire X.0Saint-Cloud, France
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NIMOTOP | 02325926 | Marketed |
Medicinal ingredients
- NIMODIPINE 30 MG per TAB